These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 35979216)

  • 41. Efficacy and safety of the CVnCoV SARS-CoV-2 mRNA vaccine candidate in ten countries in Europe and Latin America (HERALD): a randomised, observer-blinded, placebo-controlled, phase 2b/3 trial.
    Kremsner PG; Ahuad Guerrero RA; Arana-Arri E; Aroca Martinez GJ; Bonten M; Chandler R; Corral G; De Block EJL; Ecker L; Gabor JJ; Garcia Lopez CA; Gonzales L; Granados González MA; Gorini N; Grobusch MP; Hrabar AD; Junker H; Kimura A; Lanata CF; Lehmann C; Leroux-Roels I; Mann P; Martinez-Reséndez MF; Ochoa TJ; Poy CA; Reyes Fentanes MJ; Rivera Mejia LM; Ruiz Herrera VV; Sáez-Llorens X; Schönborn-Kellenberger O; Schunk M; Sierra Garcia A; Vergara I; Verstraeten T; Vico M; Oostvogels L;
    Lancet Infect Dis; 2022 Mar; 22(3):329-340. PubMed ID: 34826381
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of curcumin-pipeine supplementation on clinical status, mortality rate, oxidative stress, and inflammatory markers in critically ill ICU patients with COVID-19: a structured summary of a study protocol for a randomized controlled trial.
    Askari G; Alikiaii B; Soleimani D; Sahebkar A; Mirjalili M; Feizi A; Iraj B; Bagherniya M
    Trials; 2021 Jul; 22(1):434. PubMed ID: 34229742
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Efficacy and safety of Yiqi Peiyuan granules for improving the short-term prognosis of patients with acute kidney injury: A multicenter, double-blind, placebo-controlled, randomized trial.
    Wu JJ; Zhang TY; Qi YH; Zhu MY; Fang Y; Qi CJ; Cao LO; Lu JF; Lu BH; Tang LM; Shen JX; Mou S
    J Integr Med; 2024 May; 22(3):279-285. PubMed ID: 38688809
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Treating influenza patients of wind-heat affecting Fei syndrome by jinhua qinggan granule: a double-blinded randomized control trial].
    Li GQ; Zhao J; Tu ZT; Li JB; Liu QQ; Shi LQ; Miao Q; Yuan HQ; Liu XQ; Long YY; Liu ZG; Zhao T; Li L; Tant QH; He YC; Bian YJ; Hu JQ
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2013 Dec; 33(12):1631-5. PubMed ID: 24517059
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Homeopathy for COVID-19 in primary care: A randomized, double-blind, placebo-controlled trial (COVID-Simile study).
    Adler UC; Adler MS; Padula AEM; Hotta LM; de Toledo Cesar A; Diniz JNM; de Freitas Santos H; Martinez EZ
    J Integr Med; 2022 May; 20(3):221-229. PubMed ID: 35339397
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Safety and efficacy of herbal extracts to restore respiratory health and improve innate immunity in COVID-19 positive patients with mild to moderate severity: A structured summary of a study protocol for a randomised controlled trial.
    Rangnekar H; Patankar S; Suryawanshi K; Soni P
    Trials; 2020 Nov; 21(1):943. PubMed ID: 33225970
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficacy and Safety of Ganduqing Granules in Treating the Common Cold: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial.
    Wang Y; Zhou P; Wu Y; Cao H; Hao W; Wang F; Guo J
    Evid Based Complement Alternat Med; 2022; 2022():5105503. PubMed ID: 35722165
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Don't Fear the Reefer-Evidence Mounts for Plant-Based Cannabidiol as Treatment for Epilepsy.
    Perry MS
    Epilepsy Curr; 2019; 19(2):93-95. PubMed ID: 30955420
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Baidu Jieduan granules, traditional Chinese medicine, in the treatment of moderate coronavirus disease-2019 (COVID-19): study protocol for an open-label, randomized controlled clinical trial.
    Zhang W; Xie Q; Xu X; Sun S; Fan T; Wu X; Qu Y; Che J; Huang T; Li H; Zheng Y; Jiang C; Fang B; Zhou S
    Trials; 2021 Jul; 22(1):476. PubMed ID: 34294144
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Controlled, double-blind, randomized trial to assess the efficacy and safety of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in healthcare personnel in the hospital setting: A structured summary of a study protocol for a randomised controlled trial.
    Cuadrado-Lavín A; Olmos JM; Cifrian JM; Gimenez T; Gandarillas MA; García-Saiz M; Rebollo MH; Martínez-Taboada V; López-Hoyos M; Fariñas MC; Crespo J
    Trials; 2020 Jun; 21(1):472. PubMed ID: 32493494
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inflawell
    Barzin Tond S; Balenci L; Khajavirad N; Salehi M; Tafakhori A; Shahmohammadi MR; Ghiasvand F; Jafari S; Abolghasemi S; Mokhtari F; Mahmoodi Baram S; Zarei T; Kazemi D; Mohammadnejad E; Shah-Hosseini A; Haghbin Toutounchi A; Fallah S; Riazi A; Karima S
    Inflammopharmacology; 2022 Apr; 30(2):465-475. PubMed ID: 35201518
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Assessment of boron-containing compounds and oleoylethanolamide supplementation on the recovery trend in patients with COVID-19: A structured summary of a study protocol for a randomized controlled trial.
    Tutunchi H; Mobasseri M; Pourmoradian S; Soleimanzadeh H; Kafil B; Akbari N; Monshikarimi A; Ostadrahimi A
    Trials; 2020 Oct; 21(1):890. PubMed ID: 33109244
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A structured summary of a study protocol for a multi-center, randomized controlled trial (RCT) of COVID-19 prevention with Kampo medicines (Integrative Management in Japan for Epidemic Disease by prophylactic study: IMJEDI P1 study).
    Namiki T; Takayama S; Arita R; Ishii T; Kainuma M; Makino T; Mimura M; Yoshino T; Nogami T; Arai M; Sato J; Tanaka K; Nakae H; Igari H; Ozawa Y; Shiko Y; Kawasaki Y; Nezu M; Ito T
    Trials; 2021 Jan; 22(1):23. PubMed ID: 33407828
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of Licorice on clinical symptoms and laboratory signs in moderately ill patients with pneumonia from COVID-19: A structured summary of a study protocol for a randomized controlled trial.
    Safa O; Hassani-Azad M; Farashahinejad M; Davoodian P; Dadvand H; Hassanipour S; Fathalipour M
    Trials; 2020 Sep; 21(1):790. PubMed ID: 32933552
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Efficacy and safety of oral immunotherapy with AR101 in European children with a peanut allergy (ARTEMIS): a multicentre, double-blind, randomised, placebo-controlled phase 3 trial.
    O'B Hourihane J; Beyer K; Abbas A; Fernández-Rivas M; Turner PJ; Blumchen K; Nilsson C; Ibáñez MD; Deschildre A; Muraro A; Sharma V; Erlewyn-Lajeunesse M; Zubeldia JM; De Blay F; Sauvage CD; Byrne A; Chapman J; Boralevi F; DunnGalvin A; O'Neill C; Norval D; Vereda A; Skeel B; Adelman DC; du Toit G
    Lancet Child Adolesc Health; 2020 Oct; 4(10):728-739. PubMed ID: 32702315
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Efficacy and safety of Qi-Wei-Qing-Yan aerosol in treatment of acute pharyngitis (lung-stomach excess-heat syndrome): study protocol for a randomized controlled trial.
    Jiang HL; She B; Liu W; Mao B; Zhang JY
    Trials; 2016 Feb; 17():99. PubMed ID: 26896352
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: a double-blind, randomised, placebo-controlled, phase 2 trial.
    Maher TM; Corte TJ; Fischer A; Kreuter M; Lederer DJ; Molina-Molina M; Axmann J; Kirchgaessler KU; Samara K; Gilberg F; Cottin V
    Lancet Respir Med; 2020 Feb; 8(2):147-157. PubMed ID: 31578169
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of pomegranate juice (Punica Granatum) on inflammatory biomarkers and complete blood count in patients with COVID-19: a structured summary of a study protocol for a randomized clinical trial.
    Yousefi M; Sadriirani M; PourMahmoudi A; Mahmoodi S; Samimi B; Hosseinikia M; Saeedinezhad Z; Panahande SB
    Trials; 2021 Apr; 22(1):246. PubMed ID: 33810808
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Traditional Chinese Medicine JingYinGuBiao Formula Therapy Improves the Negative Conversion Rate of SARS-CoV2 in Patients with Mild COVID-19.
    Chen B; Geng P; Shen J; Liangpunsakul S; Lyu H; Zhang J; Yang Y; Zhang L; Xu Y; Dong C; Wang Y; Xue Y; Zhang W; Liu H; Li M; Gao Y
    Int J Biol Sci; 2022; 18(15):5641-5652. PubMed ID: 36263182
    [No Abstract]   [Full Text] [Related]  

  • 60. Effects of Lianhuaqingwen Capsules in adults with mild-to-moderate coronavirus disease 2019: an international, multicenter, double-blind, randomized controlled trial.
    Zheng JP; Ling Y; Jiang LS; Mootsikapun P; Lu HZ; Chayakulkeeree M; Zhang LX; Arttawejkul P; Hu FY; Truong TNL; Perez RA; Gu X; Sun HM; Jiang JJ; Liu RJ; Ding Z; Zhan YQ; Yang ZF; Guan WJ; Zhong NS
    Virol J; 2023 Nov; 20(1):277. PubMed ID: 38017515
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.